What does DR HERSSENS HART-EN VAATZIEKTEN do?

DR HERSSENS HART-EN VAATZIEKTEN is a specialist medical practice in Puurs-Sint-Amands. Private Limited, started on 17 July 1996, 1 establishment.

What is the address of DR HERSSENS HART-EN VAATZIEKTEN?

The registered office of DR HERSSENS HART-EN VAATZIEKTEN is located at Eikevlietbaan 44, 2870 Puurs-Sint-Amands.

Is DR HERSSENS HART-EN VAATZIEKTEN still active?

Yes. According to the CBE (16 September 2026) DR HERSSENS HART-EN VAATZIEKTEN is active, legal situation “Normale toestand”, started on 17 July 1996.

Is DR HERSSENS HART-EN VAATZIEKTEN registered on Peppol?

Yes, DR HERSSENS HART-EN VAATZIEKTEN is registered on the Peppol network with ID 0208:0458531965.

What is the enterprise number of DR HERSSENS HART-EN VAATZIEKTEN?

The enterprise number of DR HERSSENS HART-EN VAATZIEKTEN is BE0458531965.

When was DR HERSSENS HART-EN VAATZIEKTEN founded?

DR HERSSENS HART-EN VAATZIEKTEN was founded on 17 July 1996.

Who are the directors of DR HERSSENS HART-EN VAATZIEKTEN?

According to the 2025 annual accounts, the directors of DR HERSSENS HART-EN VAATZIEKTEN are: Michel Herssens.

Is DR HERSSENS HART-EN VAATZIEKTEN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 17 July 1996; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR HERSSENS HART-EN VAATZIEKTEN make in 2025?

DR HERSSENS HART-EN VAATZIEKTEN posted a profit after taxes of € 33,897 in financial year 2025.

What is the revenue of DR HERSSENS HART-EN VAATZIEKTEN?

As a small company, DR HERSSENS HART-EN VAATZIEKTEN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 144,205.

DR HERSSENS HART-EN VAATZIEKTEN (Private Limited)

Dossier DR HERSSENS HART-EN VAATZIEKTEN, printed on 16 September 2026 from databakkes.be/en/0458531965/dr-herssens-hart-en-vaatziekten. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR HERSSENS HART-EN VAATZIEKTEN from Puurs-Sint-Amands, company number BE0458531965, closed financial year 2025 with a result of € 33,897 after tax. For that financial year DR HERSSENS HART-EN VAATZIEKTEN recorded a gross margin of € 144,205 and equity of € 710,094. Compared with financial year 2024, the result moved from € 53,913 to € 33,897. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 20, 2026.

What it is worth Growing

€ 710,094

▲ 5% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 33,897

▼ 37% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 24,716

▼ 94% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 697,486.

People and assets in 2025

Wage cost

€ 86,478

▲ 1% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 94,533

▼ 21% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 140,334

▼ 27% vs 2024

€ 37,411 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 8,916

▼ 57% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 19,896

▼ 73% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 246,577 Gross margin 2022: € 246,577 First fiscal year in the series	€ 429,192 Gross margin 2023: € 429,192 ▲ 74% vs 2022 (€ 246,577) Favourable step	€ 197,182 Gross margin 2024: € 197,182 ▼ 54% vs 2023 (€ 429,192) Unfavourable step	€ 144,205 Gross margin 2025: € 144,205 ▼ 27% vs 2024 (€ 197,182) Unfavourable step	▼ 27%
Profit after taxes	€ 70,448 Profit after taxes 2022: € 70,448 First fiscal year in the series	€ 217,269 Profit after taxes 2023: € 217,269 ▲ 208% vs 2022 (€ 70,448) Favourable step	€ 53,913 Profit after taxes 2024: € 53,913 ▼ 75% vs 2023 (€ 217,269) Unfavourable step	€ 33,897 Profit after taxes 2025: € 33,897 ▼ 37% vs 2024 (€ 53,913) Unfavourable step	▼ 37%
Equity	€ 501,014 Equity 2022: € 501,014 First fiscal year in the series	€ 718,283 Equity 2023: € 718,283 ▲ 43% vs 2022 (€ 501,014) Favourable step	€ 676,197 Equity 2024: € 676,197 ▼ 6% vs 2023 (€ 718,283) Unfavourable step	€ 710,094 Equity 2025: € 710,094 ▲ 5% vs 2024 (€ 676,197) Favourable step	▲ 5%
Total debts	€ 196,848 Total debts 2022: € 196,848 First fiscal year in the series	€ 198,915 Total debts 2023: € 198,915 ▲ 1% vs 2022 (€ 196,848) Unfavourable step	€ 292,691 Total debts 2024: € 292,691 ▲ 47% vs 2023 (€ 198,915) Unfavourable step	€ 173,681 Total debts 2025: € 173,681 ▼ 41% vs 2024 (€ 292,691) Favourable step	▼ 41%
Cash	€ 195,514 Cash 2022: € 195,514 First fiscal year in the series	€ 238,135 Cash 2023: € 238,135 ▲ 22% vs 2022 (€ 195,514) Favourable step	€ 402,715 Cash 2024: € 402,715 ▲ 69% vs 2023 (€ 238,135) Favourable step	€ 24,716 Cash 2025: € 24,716 ▼ 94% vs 2024 (€ 402,715) Unfavourable step	▼ 94%
Land & buildings	€ 206,644 Land & buildings 2022: € 206,644 First fiscal year in the series	€ 199,211 Land & buildings 2023: € 199,211 ▼ 4% vs 2022 (€ 206,644) Unchanged	€ 191,778 Land & buildings 2024: € 191,778 ▼ 4% vs 2023 (€ 199,211) Unchanged	€ 184,345 Land & buildings 2025: € 184,345 ▼ 4% vs 2024 (€ 191,778) Unchanged	▼ 4%
Retained profit	€ 488,406 Retained profit 2022: € 488,406 First fiscal year in the series	€ 705,675 Retained profit 2023: € 705,675 ▲ 44% vs 2022 (€ 488,406) Favourable step	€ 663,589 Retained profit 2024: € 663,589 ▼ 6% vs 2023 (€ 705,675) Unfavourable step	€ 697,486 Retained profit 2025: € 697,486 ▲ 5% vs 2024 (€ 663,589) Favourable step	▲ 5%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 96,000 Dividend 2024: € 96,000 Unchanged (€ 0) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 96,000) Unchanged	▼ 100%
Bank debt	€ 131,699 Bank debt 2022: € 131,699 First fiscal year in the series	€ 110,454 Bank debt 2023: € 110,454 ▼ 16% vs 2022 (€ 131,699) Favourable step	€ 193,446 Bank debt 2024: € 193,446 ▲ 75% vs 2023 (€ 110,454) Unfavourable step	€ 140,334 Bank debt 2025: € 140,334 ▼ 27% vs 2024 (€ 193,446) Favourable step	▼ 27%
Balance sheet total	€ 697,862 Balance sheet total 2022: € 697,862 First fiscal year in the series	€ 917,198 Balance sheet total 2023: € 917,198 ▲ 31% vs 2022 (€ 697,862) Unchanged	€ 968,887 Balance sheet total 2024: € 968,887 ▲ 6% vs 2023 (€ 917,198) Unchanged	€ 883,774 Balance sheet total 2025: € 883,774 ▼ 9% vs 2024 (€ 968,887) Unchanged	▼ 9%

Key figures of DR HERSSENS HART-EN VAATZIEKTEN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR HERSSENS HART-EN VAATZIEKTEN?

What happened at DR HERSSENS HART-EN VAATZIEKTEN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 20, 2026 New annual accounts for financial year 2025: profit of € 33,897 (▼ 37% vs 2024). filed late Source: NBB ↗
Jul 17, 1996 New establishment in Puurs-Sint-Amands. KBO
Jul 17, 1996 Start of the company according to the CBE. KBO

In short

From € 70,448 profit in 2022 to € 33,897 profit in 2025.

Paid € 194,713 in corporate taxes since 2022.

Best year ever: 2023, with € 217,269 profit.

Paid out € 96,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR HERSSENS HART-EN VAATZIEKTEN? We notify you, reason included.

Follow DR HERSSENS HART-EN VAATZIEKTEN

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit